Welcome to the first GreyRigge Associates newsletter. The aim is to keep you up to date with topical articles that reflect the latest news and happenings in the global biopharmaceutical sector.
GreyRigge Associates work with a variety of international organisations across a variety of biopharmaceutical product types. By understanding the challenges facing companies, this broad exposure provides insight on those aspects of the business that people are talking about, whether regulatory, technical or commercial, which are regularly reflected in the GreyRigge website blog.
Below you’ll find a summary of recent blog posts from our website and links to the full articles if you wish to continue reading them.
Small Biotech & their Contract Manufacturing Organisation Partners
I’ve been working closely with contract manufacturing organisations (CMOs) for many years now. Some of these have been in the USA, some in Europe and some in Asia. What they have in common is that all have been a vital component in the development and manufacturing strategy of the organisations that I’ve been working for. Continue Reading
Building a Process Control Strategy
Frequently when a process development team are putting together the upstream and downstream components of their processes, the last thing on their minds is the performance of the tests or assays that they’ll be measuring it by. Continue Reading
Balancing the Statistical Tightrope
During one development meeting early in my industrial career, a process development group member asked me whether the value my group had reported in one result was okay to use. I confidently replied “Yes, it’s fine. It’s about 40, somewhere between 38 and 42. The other person raised his eyebrows – an answer not met with full understanding, but rather concern. Continue Reading
CEPI Vaccine Fund
Last October (2016) I posted an article on whether there should be a global vaccine development fund. Therefore, I was very excited to see an announcement made at the World Economic Forum in Davos, Switzerland on January 18th (2017) that a new global coalition had been formed; the Coalition of Epidemic Preparedness Innovations, or CEPI. Continue Reading
That’s it for now but if there are any other topics you wish to hear or read about, or you simply want to know more about the services that we offer then please do feel free to get in touch.
Principal Consultant, GreyRigge Associates Ltd
+44 118 9791169
Complete your details and we’ll send you regular updates via our newsletter.
Need to understand some element of the biopharma industry or looking for a particular template?